Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Eliminating the Hidden Student Loan Tax Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Eliminating the Hidden Student Loan Tax Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2016 · first_quarter · Q1
Medicare and Medicaid Provisions reimbursement; Agriculture, Rural Development, Food and Drug Administration Appropriations
Junk Fax regulations and interpretations, and rule promulgations
Source: Senate LDA
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Great Lakes Ecological and Economic Protection Act of 2015
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Great Lakes Ecological and Economic Protection Act of 2015
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Great Lakes Ecological and Economic Protection Act of 2015
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Great Lakes Ecological and Economic Protection Act of 2015
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Stop Tampering of Prescription Pills Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Troll bills
Preserve Access to Affordable Generics Act
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Prescription Drug Abuse Prevention and Treatment Act of 2013
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Troll bills
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Preserving Access to Life-Saving Medications Act of 2011
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Food and Drug Administration Reform Act of 2012
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Food and Drug Administration Reform Act of 2012
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Food and Drug Administration Reform Act of 2012
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Food and Drug Administration Reform Act of 2012
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Food and Drug Administration Reform Act of 2012
Client: ALLERGAN USA, INC. · Firm: ALLERGAN USA, INC.
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Drug Labeling Drug Importation Track and Trace
Drug safety and efficacy; bioequivalence.
Tax Policy including changes to corporate tax structure
Patent Reform Proposals; Patent Settlement Proposals.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · fourth_quarter · Q4
Patent Reform Proposals; Patent Settlement Proposals.
Drug safety and efficacy; bioequivalence.
Tax Policy including changes to corporate tax structure
Medicare and Medicaid Provisions reimbursement; Agriculture, Rural Development, Food and Drug Administration Appropriations
Drug Labeling Drug Importation Track and Trace
Junk Fax regulations and interpretations, and rule promulgations
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · third_quarter · Q3
Drug safety and efficacy; bioequivalence.
Tax Policy including changes to corporate tax structure
Medicare and Medicaid Provisions reimbursement; Agriculture, Rural Development, Food and Drug Administration Appropriations
Patent Reform Proposals; Patent Settlement Proposals.
Drug Labeling Drug Importation Track and Trace
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Junk Fax regulations and interpretations, and rule promulgations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · second_quarter · Q2
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Tax Policy including changes to corporate tax structure
Junk Fax regulations and interpretations, and rule promulgations
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration.
Drug Labeling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2015 · first_quarter · Q1
Tax Policy including changes to corporate tax structure
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Junk Fax regulations and interpretations, and rule promulgations
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration.
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Drug Labeling
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2014 · fourth_quarter · Q4
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Drug Labeling
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2014 · third_quarter · Q3
Junk Fax regulations and interpretations, and rule promulgations
Junk Fax regulations and interpretations, and rule promulgations
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2014 · second_quarter · Q2
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration.
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Junk Fax regulations and interpretations, and rule promulgations
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2014 · first_quarter · Q1
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Drug Labeling
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2013 · fourth_quarter · Q4
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Junk Fax regulations and interpretations, and rule promulgations
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2013 · third_quarter · Q3
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2013 · second_quarter · Q2
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; FDA funding
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2013 · first_quarter · Q1
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; FDA funding
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Junk Fax regulations and interpretations, and rule promulgations
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2012 · fourth_quarter · Q4
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
Junk Fax regulations and interpretations, and rule promulgations
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2012 · third_quarter · Q3
Junk Fax regulations and interpretations, and rule promulgations
Kidney Disease Education governement partnership opportunities for research and development
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2012 · third_quarter · Q3
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Kidney Disease Education governement partnership opportunities for research and development
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2012 · second_quarter · 2A
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Junk Fax regulations and interpretations, and rule promulgations
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2012 · second_quarter · Q2
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2012 · first_quarter · Q1
Kidney Disease Education governement partnership opportunities for research and development
Junk Fax regulations and interpretations, and rule promulgations
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2011 · fourth_quarter · Q4
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Kidney Disease Education governement partnership opportunities for research and development
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2011 · third_quarter · Q3
Junk Fax regulations and interpretations, and rule promulgations
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2011 · second_quarter · Q2
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Kidney Disease Education governement partnership opportunities for research and development
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2011 · first_quarter · Q1
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act
Prescrition Drug User Fees; The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296);
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2010 · fourth_quarter · Q4
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2010 · third_quarter · Q3
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2010 · first_quarter · 1A
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2010 · second_quarter · Q2
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Part B Medicare reimbursement issues
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2010 · first_quarter · Q1
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2009 · fourth_quarter · Q4
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3962, HR 3780, and S. 1728.
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2009 · third_quarter · Q3
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2009 · second_quarter · Q2
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2009 · first_quarter · Q1
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2008 · fourth_quarter · 4A
S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)
H.R.1193/S.691 Kidney Care Quality and Education Act of 2007
Agriculture Appropriations for FY 2009: FDA (OGD) Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2008 · fourth_quarter · 4A
S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S.242/S.251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting/pedigree issues. H.R.5839 Safeguarding America's Pharmaceuticals Act of 2008 Various bill and amendments relating to drug importation The Food and Drug Amendments Act of 2007 H.R.3610 Food and Drug Import Safety Act of 2007 Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.
Agriculture Appropriations for FY 2009: FDA (OGD) Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
ALLERGAN USA, INC. via ALLERGAN USA, INC.
2008 · fourth_quarter · Q4
H.R.1193/S.691 Kidney Care Quality and Education Act of 2007
Agriculture Appropriations for FY 2009: FDA (OGD) Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
H.R.1908, S.1145 Patent Reform Act of 2007 H.R.806 To Amend the FD&C Act to Prohibit the Marketing of Authorized Generics S.438 Fair Prescription Drug Competition Act H.R.1038, S.623 Access to Life Saving Medicines Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R.5629 Pathway for Biosimilars Act H.R.1902 Protecting Consumers Access to Generic Drugs Act of 2007 S.316 Preserve Access to Affordable Generics Act
Tax policy implications
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration.
Junk Fax regulations and interpretations, and rule promulgations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration.
Drug Labeling
Tax policy implications
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug Labeling
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Junk Fax regulations and interpretations, and rule promulgations
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Reform bills
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and R
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
Trans-Pacific Partnership content
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; FDA funding
Drug Labeling
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements, Patent Troll bills
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
Junk Fax regulations and interpretations, and rule promulgations
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; FDA funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Junk Fax regulations and interpretations, and rule promulgations
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S. 214 - Preserve Access to Affordable Generics Act;S. 504 - Fair And Immediate Release of Generic Drugs Act; patent settlements
The Prescription Drug Marketing Act;conterfit/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse;H.R. 1285 - To amend the Controlled Substances Act; H.R. 486 Stop Tampering of Prescription Pills Act of 2013;H.R. 672 - Prescription Drug Abuse Prevention and Treatment Act of 2013S. 216 - Safe Prescribing Act of 2013;S. 504 - Fair And Immediate Release of Generic Drugs Act;S. 348
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Kidney Disease Education governement partnership opportunities for research and development
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Junk Fax regulations and interpretations, and rule promulgations
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Kidney Disease Education governement partnership opportunities for research and development
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Junk Fax regulations and interpretations, and rule promulgations
Kidney Disease Education governement partnership opportunities for research and development
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies; Fuding of FDA; S3187, HR 5651
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues; Drug safety and inspection of drug manufacturing facilities; Prescription Drug Abuse; H.R. 1316, Stop Oxy Abuse Act; H.R. 1065, Pill Mill Crackdown Act; Patient Protection and Affordable Care Act; H.R. 1483, Drug Safety Enhancement Act; Drug shortages; Preserving Access to Life-Saving Medications Act (S. 296); H.R.2245,Preserving Access to Life-Saving Medications Act of 2011
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy and coverage issues
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act S. 1882, Fair and Immediate Release of Generic Drug Act
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Junk Fax regulations and interpretations, and rule promulgations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Kidney Disease Education governement partnership opportunities for research and development
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
S. 23, H.R.1249, The America Invents Act S. 27 Preserve Access to Life Saving Medicine Act Patient Protection and Affordable Care Act
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Kidney Disease Education governement partnership opportunities for research and development
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), SENATE
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275) Reimbursement policy
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009 Health Care Reform, including H.R. 3200, Americas Healthy Future Act, S. 1679, the Affordable Health Choices Act, HR 3590, HR 3780, and S. 1728. H.R. 3962, Affordable Healthcare for America S. 3590, Patient Protection and Affordable Care Act H.R. 2847
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act S. 369, Preserve Access to Affordable Generics Act of 2009 H.R. 1706, Protecting Consumer Access to Generic Drugs Act of 2009
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
H.R. 306, Kidney Disease Education Benefits Act of 2009 governement partnership opportunities for research and development
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions Appropriations Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
H.R. 306, Kidney Disease Education Benefits Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
H.R. 306, Kidney Disease Education Benefits Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 306, Kidney Disease Education Benefits Act of 2009
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009
H.R. 306, Kidney Disease Education Benefits Act of 2009
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S.242/S.251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting/pedigree issues. H.R.5839 Safeguarding America's Pharmaceuticals Act of 2008 Various bill and amendments relating to drug importation The Food and Drug Amendments Act of 2007 H.R.3610 Food and Drug Import Safety Act of 2007 Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.
H.R.1908, S.1145 Patent Reform Act of 2007 H.R.806 To Amend the FD&C Act to Prohibit the Marketing of Authorized Generics S.438 Fair Prescription Drug Competition Act H.R.1038, S.623 Access to Life Saving Medicines Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R.5629 Pathway for Biosimilars Act H.R.1902 Protecting Consumers Access to Generic Drugs Act of 2007 S.316 Preserve Access to Affordable Generics Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.1193/S.691 Kidney Care Quality and Education Act of 2007
H.R.1908, S.1145 Patent Reform Act of 2007 H.R.806 To Amend the FD&C Act to Prohibit the Marketing of Authorized Generics S.438 Fair Prescription Drug Competition Act H.R.1038, S.623 Access to Life Saving Medicines Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R.5629 Pathway for Biosimilars Act H.R.1902 Protecting Consumers Access to Generic Drugs Act of 2007 S.316 Preserve Access to Affordable Generics Act
S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S.242/S.251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting/pedigree issues. H.R.5839 Safeguarding America's Pharmaceuticals Act of 2008 Various bill and amendments relating to drug importation The Food and Drug Amendments Act of 2007 H.R.3610 Food and Drug Import Safety Act of 2007 Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.
S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE